RGC: Regal Entertainment Group - Summary | Jitta

Regal Entertainment Group

NYSE:RGC

Price
$28.58
Loss Chance
59.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (7)
Recent Business Performance (17)
Financial Strength (29)
Return to Shareholders (0)
Competitive Advantage (7)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 186.90% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
3.06
94.50%
3.06
207.06%
Pharmaceuticals
4.95
56.06%
5.05
80.16%
5.69
90.27%
COMPANY DESCRIPTION
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.